T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 01/31/2016
Volatility and Other Measures
as of 01/31/2016
Beta N/A
N/A
Standard Deviation N/A
Price/Earnings Ratio (Domestic) 18.7
Earnings Growth Rate (Domestic) 12
Turnover Rate N/A
Median Market
Capitalization
$32,881.58 Million
10 Largest Holdings
Represents 34.50 % of Total Net Assets
View Holdings as of:
Aetna
Alexion Pharmaceuticals
Allergan
Cigna
Gilead Sciences
Humana
Incyte
Regeneron Pharmaceuticals
Thermo Fisher Scientific
UnitedHealth Group
As of 01/31/2016 the Health Sciences Fund had a total of 147 holdings.
Sector Diversification
as of 01/31/2016
% of Total Net Assets
Services 33.6%
Biotechnology 25.2%
Pharmaceuticals 23.8%
Products & Devices 10.2%
Life Sciences 5.7%
See Glossary for additional details on all data elements.